Works matching DE "VALGANCICLOVIR"

Results: 304

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Published in:

OncoImmunology, 2015, v. 4, n. 2, p. N.PAG, doi. 10.4161/2162402X.2014.982391

By:

Rahbar, Afsar;
Solberg, Nina Wolmer;
Taher, Chato;
Dzabic, Mensur;
Xu, Xinling;
Skarman, Petra;
Fornara, Olesja;
Tammik, Charlotte;
Yaiw, Koon;
Wilhelmi, Vanessa;
Assinger, Alice;
Söderberg-Naucler, Cecilia;
Peredo, Inti;
Stragliotto, Giuseppe

Publication type:

Article

Cytomegalovirus viremia and hepatitis B reactivation in patient with RET fusion-positive non-small cell lung cancer treated with pralsetinib.

Published in:

Journal of Oncology Pharmacy Practice, 2025, v. 31, n. 4, p. 674, doi. 10.1177/10781552241304000

By:

Lehman, Alanna;
Perissinotti, Anthony;
Aitken, Sam

Publication type:

Article

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1518258

By:

Teng, Haolin;
Zhang, Shengnan;
Yu, Jinyu;
Li, Faping

Publication type:

Article

Association of Neutropenia With Valganciclovir Prophylaxis Dosing Practices Within Pediatric Solid Organ Transplant Recipients.

Published in:

Pediatric Transplantation, 2025, v. 29, n. 4, p. 1, doi. 10.1111/petr.70098

By:

Gerthoffer, Emma;
Pozderac, Amber;
Darland, Leanna;
Yasechko, Stephanie;
Crooker, Anna;
Hambrick, H. Rhodes;
Danziger‐Isakov, Lara

Publication type:

Article

Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 6, p. 1551, doi. 10.1111/bcp.16138

By:

van Vugt, Lukas K.;
Hesselink, Dennis A.;
de Winter, Brenda C. M.

Publication type:

Article

Limited sampling strategy for the estimation of the area under the concentration-time curve for ganciclovir in Chinese adult renal allograft recipients.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 677, doi. 10.1007/s00228-018-02613-w

By:

Rui, Wen-Bin;
An, Hui-Min;
Shao, Kun;
Zhai, Xiao-Hui;
Lu, Jia-Qian;
Hu, Shan-Shan;
Chen, Bing;
Zhou, Pei-Jun

Publication type:

Article

A Cross-Sectional Survey of Pediatric Infectious Disease Physicians' Approach to Congenital Cytomegalovirus Infection †.

Published in:

International Journal of Neonatal Screening (IJNS), 2023, v. 9, n. 2, p. 17, doi. 10.3390/ijns9020017

By:

Hoki, Chieko;
White, Michelle;
Pesch, Megan H.;
Melvin, Ann J.;
Park, Albert H.

Publication type:

Article

A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00352-y

By:

Katada, Yoshiki;
Umemura, Keisuke;
Nakagawa, Shunsaku;
Katsube, Yurie;
Tsuda, Masahiro;
Tanaka, Satona;
Date, Hiroshi;
Nagao, Miki;
Terada, Tomohiro

Publication type:

Article

NEW UV SPECTROPHOTOMETRIC METHOD FOR DEVELOPMENT AND VALIDATION OF VALGANCICLOVIR HYDROCHLORIDE IN BULK AND PHARMACEUTICAL DOSAGE FORMS.

Published in:

International Journal of Chemical & Pharmaceutical Analysis, 2020, v. 7, n. 2, p. 1, doi. 10.21276/ijcpa

By:

K., Karthik;
C., Jose Gnana Babu;
H. G., Sowyma

Publication type:

Article

Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience.

Published in:

2016

By:

CHENGWEI PENG;
JIALING WANG;
TANKSLEY, JARRED P.;
MOBLEY, BRET C.;
AYERS, GREGORY D.;
MOOTS, PAUL L.;
CLARK, STEPHEN W.

Publication type:

Case Study

Ganciclovir-resistant cytomegalovirus infection in renal transplantation.

Published in:

Clinical Kidney Journal, 2014, v. 7, n. 2, p. 210, doi. 10.1093/ckj/sfu005

By:

Vaz, Raquel;
Barros, Francisca;
Tavares, Isabel;
Bustorff, Manuela;
Ferreira, Inês;
Pestana, Manuel

Publication type:

Article

First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 581, doi. 10.1093/jpids/piad088

By:

Chabala, Chishala;
Jacobs, Tom G;
Moraleda, Cinta;
Ndaferankhande, John M;
Mumbiro, Vivian;
Passanduca, Alfeu;
Namuziya, Natasha;
Nalwanga, Damalie;
Musiime, Victor;
Ballesteros, Alvaro;
Domínguez-Rodríguez, Sara;
Chitsamatanga, Moses;
Cassia, Uneisse;
Nduna, Bwendo;
Bramugy, Justina;
Sacarlal, Jahit;
Madrid, Lola;
Nathoo, Kusum J;
Colbers, Angela;
Burger, David M

Publication type:

Article

Ganciclovir and Valganciclovir Use Among Infants With Congenital Cytomegalovirus: Data From a Multicenter Electronic Health Record Dataset in the United States.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2022, v. 11, n. 8, p. 379, doi. 10.1093/jpids/piac034

By:

Leung, Jessica;
Grosse, Scott D;
Yockey, Bryan;
Lanzieri, Tatiana M

Publication type:

Article

#42 A Retrospective Study of Valganciclovir Discontinuation Due to Toxicity or Intolerance in Pediatric Solid Organ Transplant Patients.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2022, v. 11, p. S2, doi. 10.1093/jpids/piac041.005

By:

Demirhan, Salih

Publication type:

Article

Comment on Dheyab AM. et al.'s "Long-Term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis".

Published in:

Ocular Immunology & Inflammation, 2025, v. 33, n. 2, p. 324, doi. 10.1080/09273948.2024.2386628

By:

Xie, Jiaxing;
Li, Ruofan;
Hong, Ying

Publication type:

Article

Authors' Reply to Letter to the Editor– in Response to: Comment on Dheyab AM et al. "Long-Term Efficacy of Oral Valganciclovir in Presumed Cytomegalovirus Unilateral Hypertensive Anterior Uveitis".

Published in:

Ocular Immunology & Inflammation, 2025, v. 33, n. 2, p. 326, doi. 10.1080/09273948.2024.2389246

By:

Dheyab, Abdulsalam M.;
Albloushi, Abdulrahman F.;
Al-Zuabi, Asma;
AlTariqi, Sulaiman M.;
Tobaigy, Mohannad F.;
Al Fawaz, Abdullah;
Abu El-Asrar, Ahmed

Publication type:

Article

Letermovir for the Management of Cytomegalovirus-associated Uveitis.

Published in:

2021

By:

Tsui, Edmund;
Gonzales, John A;
Shantha, Jessica G.;
Acharya, Nisha;
Doan, Thuy

Publication type:

journal article

In Response to: "Woo JH, Lim WK, Ho SL, et al. Characteristics of Cytomegalovirus Uveitis in Immunocompetent Patients".

Published in:

2017

By:

Sim, Shaun;
Cheung, Gemmy

Publication type:

Letter

Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.

Published in:

2017

By:

Rifkin, Lana M.;
Minkus, Caroline L.;
Pursell, Kenneth;
Jumroendararasame, Chaisiri;
Goldstein, Debra A.

Publication type:

journal article

What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT?

Published in:

2008

By:

Candoni, A.;
Simeone, E.;
Tiribelli, M.;
Pipan, C.;
Fanin, R.

Publication type:

Letter

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2006, v. 37, n. 9, p. 851, doi. 10.1038/sj.bmt.1705341

By:

Ayala, E.;
Greene, J.;
Sandin, R.;
Perkins, J.;
Field, T.;
Tate, C.;
Fields, K. K.;
Goldstein, S.

Publication type:

Article

Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients.

Published in:

Bone Marrow Transplantation, 2006, v. 37, n. 7, p. 693, doi. 10.1038/sj.bmt.1705311

By:

van der Heiden, P. L. J.;
Kalpoe, J. S.;
Barge, R. M.;
Willemze, R.;
Kroes, A. C. M.;
Schippers, E. F.

Publication type:

Article

Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.

Published in:

2020

By:

Dorfman, Lev;
Amir, Jacob;
Attias, Joseph;
Bilavsky, Efraim

Publication type:

journal article

Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.

Published in:

2010

By:

Amir, Jacob;
Wolf, Dana G.;
Levy, Itzhak

Publication type:

journal article

Valganciclovir for treatment of congenital cytomegalovirus infection.

Published in:

2006

By:

Schulzke, Sven;
Bührer, Christoph;
Bührer, Christoph

Publication type:

journal article

Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?

Published in:

Journal of Transplantation, 2018, p. 1, doi. 10.1155/2018/8414385

By:

Mozaffar, Maryam;
Shahidi, Shahrzad;
Mansourian, Marjan;
Badri, Shirinsadat

Publication type:

Article

An Alternative Approach to Isoganciclovir: A Prominent Impurity in the Antiviral Drug Ganciclovir.

Published in:

Scientia Pharmaceutica, 2015, v. 83, n. 2, p. 233, doi. 10.3797/scipharm.1409-15

By:

KAMAT, Anand G.;
PRABAHAR, Koilpillai Joseph;
GUPTA, Peruri Badarinadh;
SUNDARAM, Dhanraj T. S. S.;
RAO, Battula VENKATESWARA;
DOUGLAS, Sanasi PAUL

Publication type:

Article

An Alternative Approach to Isoganciclovir: A Prominent Impurity in the Antiviral Drug Ganciclovir.

Published in:

Scientia Pharmaceutica, 2015, v. 83, n. 2, p. 233, doi. 10.3797/scipharm.1409-15

By:

KAMAT, Anand G.;
PRABAHAR, Koilpillai Joseph;
GUPTA, Peruri Badarinadh;
SUNDARAM, Dhanraj T. S. S.;
VENKATESWARA RAO, Battula;
PAUL DOUGLAS, Sanasi

Publication type:

Article

Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.

Published in:

PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210420

By:

Lumley, Sheila;
Green, Cameron;
Rafferty, Hannah;
Smith, Colette;
Harber, Mark;
O’Beirne, James;
Jones, Gareth;
Thorburn, Douglas;
Marshall, Aileen;
Shah, Tina;
Zuhair, Mohamed;
Rothwell, Emily;
Atabani, Sowsan;
Haque, Tanzina;
Griffiths, Paul

Publication type:

Article

Population Pharmacokinetics and Bayesian Estimation of the Area Under the Concentration‐Time Curve for Ganciclovir in Adult Chinese Renal Allograft Recipients After Valganciclovir Administration.

Published in:

Journal of Clinical Pharmacology, 2021, v. 61, n. 3, p. 328, doi. 10.1002/jcph.1735

By:

Chen, Bing;
Hu, Shan‐Shan;
Rui, Wen‐Bin;
An, Hui‐Min;
Zhai, Xiao‐Hui;
Wang, Xi‐Han;
Lu, Jia‐Qian;
Shao, Kun;
Zhou, Pei‐Jun

Publication type:

Article

Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infection.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, p. S14

By:

Baillie, G. Mark

Publication type:

Article

Introduction.

Published in:

American Journal of Health-System Pharmacy, 2005, v. 62, p. S2, doi. 10.1093/ajhp/62.suppl_1.S2

By:

Baillie, G. Mark

Publication type:

Article

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab.

Published in:

2019

By:

Onda, Masahiro;
Niimi, Yusuke;
Ozawa, Kenji;
Shiraki, Ikumi;
Mochizuki, Kiyofumi;
Yamamoto, Tetsuya;
Sugita, Sunao;
Ishida, Kyoko

Publication type:

journal article

Successful Treatment with Oral Valganciclovir of Primary CMV Enterocolitis in a Congenitally Infected Infant.

Published in:

Fetal & Pediatric Pathology, 2011, v. 30, n. 6, p. 437, doi. 10.3109/15513815.2011.587501

By:

Irizarry, Karina;
Honigbaum, Stefany;
Demmler-Harrison, Gail;
Rippel, Sara;
Wilsey, Michael

Publication type:

Article

Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis.

Published in:

Transplant International, 2023, v. 36, p. 1, doi. 10.3389/ti.2023.10979

By:

Fernández-Ruiz, Mario;
Parra, Patricia;
Ruiz-Merlo, Tamara;
Redondo, Natalia;
Rodríguez-Goncer, Isabel;
Andrés, Amado;
Aguado, José María

Publication type:

Article

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation.

Published in:

Transplant International, 2022, v. 35, p. 1, doi. 10.3389/ti.2022.10332

By:

Grossi, Paolo Antonio;
Kamar, Nassim;
Saliba, Faouzi;
Baldanti, Fausto;
Aguado, Jose M.;
Gottlieb, Jens;
Banas, Bernhard;
Potena, Luciano

Publication type:

Article

Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.

Published in:

Transplant International, 2015, v. 28, n. 5, p. 594, doi. 10.1111/tri.12545

By:

Khansarinejad, Behzad;
Soleimanjahi, Hoorieh;
Mirab Samiee, Siamak;
Hamidieh, Amir Ali;
Paryan, Mahdi;
Sanahmadi, Yadollah;
Karami, Manoochehr;
Mondanizadeh, Mahdieh

Publication type:

Article

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.

Published in:

Transplant International, 2012, v. 25, n. 7, p. 723, doi. 10.1111/j.1432-2277.2012.01485.x

By:

Höcker, Britta;
Böhm, Stephan;
Fickenscher, Helmut;
Küsters, Uta;
Schnitzler, Paul;
Pohl, Martin;
John, Ulrike;
Kemper, Markus J.;
Fehrenbach, Henry;
Wigger, Marianne;
Holder, Martin;
Schröder, Monika;
Feneberg, Reinhard;
Köpf-Shakib, Sabine;
Tönshoff, Burkhard

Publication type:

Article

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

Published in:

Transplant International, 2011, v. 24, n. 9, p. 920, doi. 10.1111/j.1432-2277.2011.01285.x

By:

La Rosa, Corinna;
Limaye, Ajit P.;
Krishnan, Aparna;
Blumstein, Gideon;
Longmate, Jeff;
Diamond, Don J.

Publication type:

Article

Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.

Published in:

Transplant International, 2010, v. 23, n. 10, p. 1056, doi. 10.1111/j.1432-2277.2010.01101.x

By:

Weclawiak, Hugo;
Kamar, Nassim;
Mengelle, Catherine;
Esposito, Laure;
Mohamed, Abdellatif Ould;
Lavayssiere, Laurence;
Ribes, David;
Cointault, Olivier;
Nogier, Marie-Béatrice;
Cardeau-Desangles, Isabelle;
Izopet, Jacques;
Rostaing, Lionel

Publication type:

Article

Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.

Published in:

Transplant International, 2010, v. 23, n. 9, p. 897, doi. 10.1111/j.1432-2277.2010.01073.x

By:

Leone, Francesca;
Akl, Ahmed;
Giral, Magali;
Dantal, Jacques;
Blancho, Gilles;
Soulillou, Jean-Paul;
Cantarovich, Diego

Publication type:

Article

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.

Published in:

Transplant International, 2010, v. 23, n. 5, p. 506, doi. 10.1111/j.1432-2277.2009.01017.x

By:

Eid, Albert J.;
Brown, Robert A.;
Arthurs, Supha K.;
Lahr, Brian D.;
Eckel-Passow, Jeanette E.;
Larson, Timothy S.;
Razonable, Raymund R.

Publication type:

Article

Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 4, p. 1150, doi. 10.1093/jac/dkt472

By:

Zhang, Bo;
Fila, Marc;
Fakhoury, May;
Baudouin, Véronique;
Deschênes, Georges;
Jacqz-Aigrain, Evelyne;
Zhao, Wei

Publication type:

Article

Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 3, p. 600, doi. 10.1093/jac/dkn521

By:

Tiziano Allice;
Alessandro Busca;
Franco Locatelli;
Michele Falda;
Fabrizia Pittaluga;
Valeria Ghisetti

Publication type:

Article

Experimental and computational studies on the effects of valganciclovir as an antiviral drug on calf thymus DNA.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2017, v. 36, n. 1, p. 31, doi. 10.1080/15257770.2016.1218019

By:

Shahabadi, Nahid;
Pourfoulad, Mehdi;
Moghadam, Neda Hosseinpour

Publication type:

Article

Synthesis of a new Pt(II) complex containing valganciclovir drug and calf-thymus DNA interaction study using multispectroscopic methods.

Published in:

Journal of Coordination Chemistry, 2018, v. 71, n. 2, p. 258, doi. 10.1080/00958972.2018.1433828

By:

Shahabadi, Nahid;
Fatahi, Somaye;
Maghsudi, Maryam

Publication type:

Article

Synthesis, characterization and in vitro DNA binding studies of a new copper(II) complex containing an antiviral drug, valganciclovir.

Published in:

Journal of Coordination Chemistry, 2017, v. 70, n. 2, p. 201, doi. 10.1080/00958972.2016.1257790

By:

Shahabadi, Nahid;
Pourfoulad, Mehdi;
Taherpour, Avat (Arman)

Publication type:

Article

Primary intestinal Cytomegalovirus infection in a patient with severe ulcerative colitis.

Published in:

2023

By:

Kaazan, Patricia;
Palmer, Andrew J.;
Oliver, Kimberley;
Burger, Daniel;
Segal, Jonathan;
Chao, Che‐Yung;
Martin, Neal

Publication type:

Letter to the Editor

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship.

Published in:

Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 77, doi. 10.3390/antibiotics10010077

By:

Galar, Alicia;
Valerio, Maricela;
Catalán, Pilar;
García-González, Xandra;
Burillo, Almudena;
Fernández-Cruz, Ana;
Zataráin, Eduardo;
Sousa-Casasnovas, Iago;
Anaya, Fernando;
Rodríguez-Ferrero, María Luisa;
Muñoz, Patricia;
Bouza, Emilio

Publication type:

Article

Multicenter Analysis of Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients.

Published in:

Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae353

By:

Foca, Marc;
Demirhan, Salih;
Munoz, Flor M;
Deray, Kristen G Valencia;
Bocchini, Claire E;
Sharma, Tanvi S;
Sherman, Gilad;
Muller, William J;
Heald-Sargent, Taylor;
Danziger-Isakov, Lara;
Blum, Samantha;
Boguniewicz, Juri;
Bacon, Samantha;
Joseph, Tuhina;
Smith, Jodi;
Ardura, Monica I;
Su, Yin;
Maron, Gabriela M;
Ferrolino, Jose;
Herold, Betsy C

Publication type:

Article